Denosumab salvage therapy in a patient with a locally advanced and refractory sellar giant cell tumour of bone

This report describes use of denosumab for sellar giant cell tumour of bone, where bone tumour debulking surgery had not been successful. It highlights that surgical resection is still preferable as the definitive treatment, as denosumab use would be required long term.


The Lancet Diabetes & Endocrinology